Menu
Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
125 Summer Street
Boston, Massachusetts 02110
Phone: 17818487100
www.haemonetics.com
https://www.investing.com/news/stock-market-news/citigroup-maintains-neutral-outlook-on-haemonetics-with-a-target-price-set-at-10885-93CH-3189529
Citi has opened an upside catalyst watch for Haemonetics ahead of the medtech''s FYQ2 2024 earnings report and expects management to raise guidance. Read more here.
Martingale Asset Management L P boosted its holdings in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 3.8% during the first quarter, Holdings Channel.com reports. The firm owned 24,921 shares of the medical instruments supplier’s stock after acquiring an additional 907 shares during the period. Martingale Asset Management L P’s holdings in Haemonetics were […]
In an exciting development for investors, Haemonetics (NYSE:HAE) received an upgrade by StockNews.com from a “buy” rating to a “strong-buy” rating on August 25, 2023. On Friday, shares of HAE opened at $86.43. The company’s 50-day moving average price stands at $87.87, while the 200-day moving average price is $84.26. It’s worth noting that Haemonetics […] The post Haemonetics Receives Strong-Buy Rating and Shows Potential for Long-Term Gains appeared first on Best Stocks .
Haemonetics Co. (NYSE:HAE – Free Report) – Equities research analysts at Zacks Research reduced their Q4 2024 earnings per share (EPS) estimates for shares of Haemonetics in a report issued on Monday, August 21st. Zacks Research analyst R. Anand now anticipates that the medical instruments supplier will post earnings of $0.88 per share for the […]
